Skip to main content
. 2022 Apr;14(4):1009–1019. doi: 10.21037/jtd-21-1723

Table 2. Comparison between QFT-GIT-negative and –positive patients with pleural TB.

Variable Total (n=199) QFT-GIT-negative group (n=36) QFT-GIT-positive group (n=163) P value
Pleural AFB stain 2 (1.0%) 0 (0.0%) 2 (1.2%) 1.000
Pleural TB PCR 19 (9.5%) 4 (11.1%) 15 (9.2%) 1.000
Pleural M. tuberculosis culture 61 (30.7%) 7 (19.4%) 54 (33.1%) 0.172
Pleural microbiological evidence for M. tuberculosis 69 (34.7%) 9 (25.0%) 60 (36.8%) 0.248
Sputum AFB stain 25 (12.6%) 5 (13.9%) 20 (12.3%) 0.778
Sputum TB PCR 40 (20.1%) 8 (22.2%) 32 (19.6%) 0.730
Sputum M. tuberculosis culture 84 (42.2%) 12 (33.3%) 72 (44.2%) 0.413
Sputum microbiological evidence for M. tuberculosis 88 (44.2%) 14 (38.9%) 74 (45.4%) 0.599
Category of pleural TB 0.446
   Confirmed TB 119 (59.8%) 19 (52.8%) 100 (61.3%)
   Probable TB 80 (40.2%) 17 (47.2%) 63 (38.7%)
Site of pleural effusion 0.846
   Right 107 (53.8%) 18 (50.0%) 89 (54.6%)
   Left 57 (28.6%) 10 (27.8%) 47 (28.8%)
   Both 33 (16.6%) 7 (19.4%) 26 (16.0%)
Group by infected site of TB
   Only pleural TB 98 (49.2%) 20 (55.6%) 78 (47.9%) 0.514
   Pleural and pulmonary TB 74 (37.2%) 14 (38.9%) 60 (36.8%) 0.966
   Disseminated TB 27 (13.6%) 2 (5.6%) 25 (15.3%) 0.178

Categorical variables are presented as n (%). QFT-GIT, QuantiFERON-TB Gold In-Tube; TB, tuberculosis; AFB, acid-fast bacillus; PCR, polymerase chain reaction; M. tuberculosis, Mycobacterium tuberculosis.